These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28658439)
81. Malignancies in systemic rheumatic diseases: A mini review. Geng Z; Ye C; Zhu X Front Immunol; 2023; 14():1095526. PubMed ID: 36926334 [TBL] [Abstract][Full Text] [Related]
82. Changing incidence of orthopedic surgery in rheumatic disease: contributing factors. Bernstein EJ; Mandl LA Curr Rheumatol Rep; 2013 Oct; 15(10):365. PubMed ID: 23955065 [TBL] [Abstract][Full Text] [Related]
83. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases]. Karateev AE; Nasonova VA; Murav'ev IuV Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549 [TBL] [Abstract][Full Text] [Related]
84. Office management of rheumatic disease. Pharmacology and laboratory evaluation. McWhorter JE Orthop Clin North Am; 1988 Oct; 19(4):867-75. PubMed ID: 3262853 [TBL] [Abstract][Full Text] [Related]
85. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1. Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183 [TBL] [Abstract][Full Text] [Related]
86. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases]. Falcão S; Mourão AF; Pimentão JB; Branco JC Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198 [TBL] [Abstract][Full Text] [Related]
87. Special issue on glucocorticoid therapy in rheumatic diseases: introduction. Cutolo M; Chrousos GP; Pincus T Neuroimmunomodulation; 2015; 22(1-2):3-5. PubMed ID: 25227248 [No Abstract] [Full Text] [Related]
88. Steroids in rheumatic disease: a podiatric perspective. Roth RD Clin Podiatr Med Surg; 1988 Jan; 5(1):135-54. PubMed ID: 2962716 [TBL] [Abstract][Full Text] [Related]
89. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology. Ferraccioli G; De Santis M; Tolusso B Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877 [TBL] [Abstract][Full Text] [Related]
90. Current treatment options and safety considerations when treating adult-onset Still's disease. Cavalli G; Farina N; Campochiaro C; Baldissera E; Dagna L Expert Opin Drug Saf; 2020 Dec; 19(12):1549-1558. PubMed ID: 33078630 [TBL] [Abstract][Full Text] [Related]
91. DNA single strand-breaks in human lymphocytes after therapy with antirheumatic drugs. Reitz M; Lorei W; Lettko M Arzneimittelforschung; 1991 Nov; 41(11):1141-4. PubMed ID: 1810259 [TBL] [Abstract][Full Text] [Related]
92. Antirheumatic drugs in pregnancy and lactation. Temprano KK; Bandlamudi R; Moore TL Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696 [TBL] [Abstract][Full Text] [Related]
93. Safety of treatment options for spondyloarthritis: a narrative review. D'Angelo S; Carriero A; Gilio M; Ursini F; Leccese P; Palazzi C Expert Opin Drug Saf; 2018 May; 17(5):475-486. PubMed ID: 29505325 [TBL] [Abstract][Full Text] [Related]
94. [Aceclofenac (aertal) in rheumatological practice]. Nasonova VA Ter Arkh; 2005; 77(5):87-90. PubMed ID: 15989015 [No Abstract] [Full Text] [Related]
95. [Management of inflammatory rheumatic diseases during and after malignancies]. Schmalzing M Z Rheumatol; 2022 Nov; 81(9):766-777. PubMed ID: 35796758 [TBL] [Abstract][Full Text] [Related]
96. How Do Glucocorticoids Used in Rheumatic Disease Affect Body Weight? A Narrative Review of the Evidence. Morgan C; Costello RE; Ray DW; Dixon WG Arthritis Care Res (Hoboken); 2020 Apr; 72(4):489-497. PubMed ID: 30875454 [TBL] [Abstract][Full Text] [Related]
97. Postoperative flares and peri-arthroscopic management of immunosuppressive medications in patients with rheumatic disease. Vasavada K; Shankar DS; Avila A; Lin CC; Marulanda D; Jazrawi LM; Samuels J Knee; 2023 Mar; 41():171-179. PubMed ID: 36702051 [TBL] [Abstract][Full Text] [Related]
98. Implications of Rheumatic Disease and Biological Response-Modifying Agents in Plastic Surgery. Tsai DM; Borah GL Plast Reconstr Surg; 2015 Dec; 136(6):1327-1336. PubMed ID: 26595025 [TBL] [Abstract][Full Text] [Related]